Product Image

Alcohol & Sugar-Free Ginkgo Biloba Liquid Extract

Swanson Premium Brand
4.7
★ ★ ★ ★ ★
(834 ratings)
Ginkgo
Product Image
Score68
A flexible alcohol-free liquid with a high extract weight but no verified standardization. It may fit general circulation-focused cognitive use, not precise targeted dosing.
How scoring works
Quantity:1 Liquid(s) • (29 servings)
Goals:

Score 68

A flexible alcohol-free liquid with a high extract weight but no verified standardization. It may fit general circulation-focused cognitive use, not precise targeted dosing.
How scoring works
$11.29($0.38 per serving)
iHerb
$ 11.29
Amazon
$ 0.00
iHerb
$ 11.29
Report prices

Analysis

The liquid provides 250 mg of ginkgo extract without alcohol or sugar, which may suit users who avoid capsules. No flavone-glycoside, terpene-lactone, or ginkgolic-acid standard is supplied, so active potency is uncertain.

Ginkgo may support cerebral circulation and selected aspects of memory or processing, especially where circulation is relevant. It is less dependable as an immediate focus or productivity aid and offers only indirect vision support.

The dropper format allows dose adjustment and easy mixing. People who want clinically comparable ginkgo or multi-pathway cognitive support should favor a standardized extract or a broader formula.

Who is it for
  • Adults who prefer liquid supplements
  • People avoiding alcohol and sugar
  • Users interested in circulation-related cognition
Best for
  • Flexible ginkgo dosing
  • Capsule-free routines
  • General memory and circulation support

Pros

  • Alcohol- and sugar-free liquid
  • Clearly states extract weight
  • Flexible serving format

Cons

  • No active-marker percentages
  • Large extract weight is difficult to interpret
  • Does not cover multiple cognitive pathways

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • The flexible dropper makes accurate measurement important; do not assume more extract provides more benefit.
  • Headache, dizziness, or digestive upset can occur with ginkgo.

Nutrient quality

69 High impact

The extract amount is clear, but active-marker standardization and purity are not verified. The formula supplies an above-target extract amount with uncertain active yield, with a meaningful dose or safety limitation.

.

Ingredient transparency

77 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

68 High impact

The supplied average is very strong and the response volume is moderate. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

54 Moderate impact

Low cost alone does not establish value when active yield or appropriate dosing is uncertain. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Cognitive Support
Cognitive Support
Impact
Moderate effect
B- Goal FitC- Strength of SupportD- CoverageA- Formula Quality

Ginkgo directly targets cerebral circulation and has relevant evidence for selected memory outcomes. The liquid provides a clearly stated 250 mg extract amount.

No flavone-glycoside or terpene-lactone percentage is supplied, so active potency cannot be confirmed. Ginkgo may increase bleeding risk when used with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Mental Focus
Impact
Moderate effect
C Goal FitC Strength of SupportD- CoverageA Formula Quality

Ginkgo may modestly support clarity through cerebral circulation, but it is not a strong acute focus aid. The 250 mg extract weight is clear, while absent flavone and terpene standardization makes active potency uncertain.

The alcohol-free liquid offers depth only within one circulation-related pathway. Ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines, especially around surgery.

Study evidence
Ginkgo Supportive 28 studies
Brain Health
Brain Health
Impact
Moderate effect
C Goal FitC- Strength of SupportD- CoverageA Formula Quality

Ginkgo extract offers situational support for cerebral circulation and memory, especially in older adults. The 250 mg liquid amount is disclosed but lacks standardized marker percentages and purity limits.

The single-herb format is focused yet covers only one cognitive pathway. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Productivity Boost
Impact
Moderate effect
C+ Goal FitD Strength of SupportD- CoverageA Formula Quality

Ginkgo may support processing and mental clarity through cerebral blood-flow effects. Human evidence is modest and depends on standardized extracts with verified active markers.

The 250 mg amount is clearly disclosed, but flavone, terpene, and ginkgolic-acid standards are not provided. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Vision Support
Impact
Moderate effect
D- Goal FitD- Strength of SupportF CoverageA+ Formula Quality

Ginkgo may support ocular microcirculation when that pathway is specifically relevant. It remains less direct than carotenoids, omega fats, or established antioxidant combinations for broad vision support.

The liquid provides a substantial extract weight and simple dosing. No active-marker standardization or purity limit shows how much functional ginkgo the serving actually delivers.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba leaf extract
250 mg
Adults 18–50 Sugar Free
Report overview
Ginkgo · 250 mg OverallScore32
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyF Value

The liquid provides a clearly disclosed extract amount but no active-marker percentages or purity standard. Its daily amount is above the preferred range yet below the threshold for a clear high-dose penalty, while active yield remains uncertain. Value cannot be established because the extract is not standardized.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones combines a substantial dose with a long supply. The missing marker percentages and ginkgolic-acid limit are the main quality gaps.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A lower serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  4. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  7. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost Mental Focus forGinkgo
  8. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers.
    Kennedy DO; Scholey AB; Wesnes KA · Psychopharmacology · 2001
    Randomized trial20 participantsProductivity Boost forGinkgo
  9. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  10. Effect of single-dose Ginkgo biloba and Panax ginseng on driving performance.
    LaSala GS; McKeever RG; Patel U; Okaneku J; Vearrier D; Greenberg MI · Clinical toxicology (Philadelphia, Pa.) · 2015
    Randomized trial30 participantsProductivity Boost forGinkgo
  11. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  12. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  13. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  14. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  15. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.
    Hashiguchi M; Ohta Y; Shimizu M; Maruyama J; Mochizuki M · Journal of pharmaceutical health care and sciences · 2016
    Meta-analysis2,381 participants13 studies pooledCognitive Support forGinkgo
  16. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  17. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  18. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  19. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  20. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  21. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  22. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  23. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  24. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  25. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  26. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  27. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  28. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  29. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  30. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  31. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  32. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  33. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  34. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  35. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  36. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo